211 related articles for article (PubMed ID: 23952889)
1. A double-blind placebo-controlled trial of N-acetylcysteine in the treatment of cocaine dependence.
LaRowe SD; Kalivas PW; Nicholas JS; Randall PK; Mardikian PN; Malcolm RJ
Am J Addict; 2013; 22(5):443-52. PubMed ID: 23952889
[TBL] [Abstract][Full Text] [Related]
2. N-acetylcysteine reduces cocaine-seeking behavior and anterior cingulate glutamate/glutamine levels among cocaine-dependent individuals.
Woodcock EA; Lundahl LH; Khatib D; Stanley JA; Greenwald MK
Addict Biol; 2021 Mar; 26(2):e12900. PubMed ID: 32212237
[TBL] [Abstract][Full Text] [Related]
3. An open-label trial of N-acetylcysteine for the treatment of cocaine dependence: a pilot study.
Mardikian PN; LaRowe SD; Hedden S; Kalivas PW; Malcolm RJ
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Mar; 31(2):389-94. PubMed ID: 17113207
[TBL] [Abstract][Full Text] [Related]
4. A study protocol for the N-ICE trial: A randomised double-blind placebo-controlled study of the safety and efficacy of N-acetyl-cysteine (NAC) as a pharmacotherapy for methamphetamine ("ice") dependence.
McKetin R; Dean OM; Turner A; Kelly PJ; Quinn B; Lubman DI; Dietze P; Carter G; Higgs P; Baker AL; Sinclair B; Reid D; Manning V; Te Pas N; Liang W; Thomas T; Bathish R; Kent M; Raftery D; Arunogiri S; Cordaro F; Hill H; Berk M
Trials; 2019 Jun; 20(1):325. PubMed ID: 31164169
[TBL] [Abstract][Full Text] [Related]
5. A double blind, placebo controlled trial of modafinil for the treatment of cocaine dependence without co-morbid alcohol dependence.
Kampman KM; Lynch KG; Pettinati HM; Spratt K; Wierzbicki MR; Dackis C; O'Brien CP
Drug Alcohol Depend; 2015 Oct; 155():105-10. PubMed ID: 26320827
[TBL] [Abstract][Full Text] [Related]
6. N-acetylcysteine for treating cocaine addiction - A systematic review.
Nocito Echevarria MA; Andrade Reis T; Ruffo Capatti G; Siciliano Soares V; da Silveira DX; Fidalgo TM
Psychiatry Res; 2017 May; 251():197-203. PubMed ID: 28213190
[TBL] [Abstract][Full Text] [Related]
7. Safety and tolerability of N-acetylcysteine in cocaine-dependent individuals.
LaRowe SD; Mardikian P; Malcolm R; Myrick H; Kalivas P; McFarland K; Saladin M; McRae A; Brady K
Am J Addict; 2006; 15(1):105-10. PubMed ID: 16449100
[TBL] [Abstract][Full Text] [Related]
8. The efficacy of N-acetylcysteine in the treatment of methamphetamine dependence: a double-blind controlled, crossover study.
Mousavi SG; Sharbafchi MR; Salehi M; Peykanpour M; Karimian Sichani N; Maracy M
Arch Iran Med; 2015 Jan; 18(1):28-33. PubMed ID: 25556383
[TBL] [Abstract][Full Text] [Related]
9. A randomized placebo-controlled trial of gabapentin for cocaine dependence.
Bisaga A; Aharonovich E; Garawi F; Levin FR; Rubin E; Raby WN; Nunes EV
Drug Alcohol Depend; 2006 Feb; 81(3):267-74. PubMed ID: 16169160
[TBL] [Abstract][Full Text] [Related]
10. Randomized, double-blind, placebo-controlled trial of vigabatrin for the treatment of cocaine dependence in Mexican parolees.
Brodie JD; Case BG; Figueroa E; Dewey SL; Robinson JA; Wanderling JA; Laska EM
Am J Psychiatry; 2009 Nov; 166(11):1269-77. PubMed ID: 19651710
[TBL] [Abstract][Full Text] [Related]
11. A double-blind, placebo-controlled trial of topiramate for the treatment of comorbid cocaine and alcohol dependence.
Kampman KM; Pettinati HM; Lynch KG; Spratt K; Wierzbicki MR; O'Brien CP
Drug Alcohol Depend; 2013 Nov; 133(1):94-9. PubMed ID: 23810644
[TBL] [Abstract][Full Text] [Related]
12. A multisite, double-blind, placebo-controlled clinical trial to evaluate the safety and efficacy of vigabatrin for treating cocaine dependence.
Somoza EC; Winship D; Gorodetzky CW; Lewis D; Ciraulo DA; Galloway GP; Segal SD; Sheehan M; Roache JD; Bickel WK; Jasinski D; Watson DW; Miller SR; Somoza P; Winhusen T
JAMA Psychiatry; 2013 Jun; 70(6):630-7. PubMed ID: 23575810
[TBL] [Abstract][Full Text] [Related]
13. Is cocaine desire reduced by N-acetylcysteine?
LaRowe SD; Myrick H; Hedden S; Mardikian P; Saladin M; McRae A; Brady K; Kalivas PW; Malcolm R
Am J Psychiatry; 2007 Jul; 164(7):1115-7. PubMed ID: 17606664
[TBL] [Abstract][Full Text] [Related]
14. The effect of N-acetylcysteine and working memory training on cocaine use, craving and inhibition in regular cocaine users: correspondence of lab assessments and Ecological Momentary Assessment.
Schulte MHJ; Wiers RW; Boendermaker WJ; Goudriaan AE; van den Brink W; van Deursen DS; Friese M; Brede E; Waters AJ
Addict Behav; 2018 Apr; 79():24-31. PubMed ID: 29241082
[TBL] [Abstract][Full Text] [Related]
15. Olanzapine in cocaine dependence: a double-blind, placebo-controlled trial.
Hamilton JD; Nguyen QX; Gerber RM; Rubio NB
Am J Addict; 2009; 18(1):48-52. PubMed ID: 19219665
[TBL] [Abstract][Full Text] [Related]
16. Multisite, randomized, double-blind, placebo-controlled pilot clinical trial to evaluate the efficacy of buspirone as a relapse-prevention treatment for cocaine dependence.
Winhusen TM; Kropp F; Lindblad R; Douaihy A; Haynes L; Hodgkins C; Chartier K; Kampman KM; Sharma G; Lewis DF; VanVeldhuisen P; Theobald J; May J; Brigham GS
J Clin Psychiatry; 2014 Jul; 75(7):757-64. PubMed ID: 24911028
[TBL] [Abstract][Full Text] [Related]
17. A double-blind, placebo-controlled trial of modafinil for cocaine dependence.
Dackis CA; Kampman KM; Lynch KG; Pettinati HM; O'Brien CP
Neuropsychopharmacology; 2005 Jan; 30(1):205-11. PubMed ID: 15525998
[TBL] [Abstract][Full Text] [Related]
18. A double-blind, placebo-controlled pilot trial of acamprosate for the treatment of cocaine dependence.
Kampman KM; Dackis C; Pettinati HM; Lynch KG; Sparkman T; O'Brien CP
Addict Behav; 2011 Mar; 36(3):217-21. PubMed ID: 21112155
[TBL] [Abstract][Full Text] [Related]
19. A double-blind randomized controlled trial of N-acetylcysteine in cannabis-dependent adolescents.
Gray KM; Carpenter MJ; Baker NL; DeSantis SM; Kryway E; Hartwell KJ; McRae-Clark AL; Brady KT
Am J Psychiatry; 2012 Aug; 169(8):805-12. PubMed ID: 22706327
[TBL] [Abstract][Full Text] [Related]
20. N-Acetylcysteine for Pediatric Obsessive-Compulsive Disorder: A Small Pilot Study.
Li F; Welling MC; Johnson JA; Coughlin C; Mulqueen J; Jakubovski E; Coury S; Landeros-Weisenberger A; Bloch MH
J Child Adolesc Psychopharmacol; 2020 Feb; 30(1):32-37. PubMed ID: 31800306
[No Abstract] [Full Text] [Related]
[Next] [New Search]
